Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.88 EUR | 0.00% |
|
+1.14% | +10.28% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company has a low valuation given the cash flows generated by its activity.
- The company is one of the best yield companies with high dividend expectations.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Historically, the company has been releasing figures that are above expectations.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+10.28% | 4.84B | - | ||
+25.59% | 45.93B | B- | ||
+36.11% | 23.66B | B+ | ||
+29.93% | 16.25B | - | ||
+20.84% | 14.63B | B+ | ||
+68.80% | 14.22B | B | ||
-0.05% | 6.79B | - | - | |
-11.31% | 6.3B | B+ | ||
+15.26% | 5.77B | B+ | ||
-8.87% | 5.73B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- RICHTER Stock
- RIG2 Stock
- Ratings Gedeon Richter